Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement

Amyotrophic lateral sclerosis (ALS) is a clinically progressive neurodegenerative syndrome predominantly affecting motor neurons and their associated tracts. Riluzole and edaravone are the only FDA certified drugs for treating ALS. Over the past two decades, almost all clinical trials aiming to deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Katyal, Nakul, Govindarajan, Raghav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626834/
https://www.ncbi.nlm.nih.gov/pubmed/29033893
http://dx.doi.org/10.3389/fneur.2017.00521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626834/
https://www.ncbi.nlm.nih.gov/pubmed/29033893
http://dx.doi.org/10.3389/fneur.2017.00521

Ejemplares similares